Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Biography

Meet Our Editorial Board Member

Author(s): Dafin F. Muresanu

Volume 19, Issue 4, 2020

Page: [241 - 242] Pages: 2

DOI: 10.2174/187152731904200907100520

Next »

Rights & Permissions Print Cite

Article Metrics

25

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Pharmacological Support of Neurorehabilitation
Current Drug Therapy

Transdermal Oxandrolone: Ex Vivo Percutaneous Absorption Study
Current Drug Delivery

Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems
Current Drug Targets

Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management
Current Pharmaceutical Design

Cannabinoid Modulation of Neuroinflammatory Disorders
Current Neuropharmacology

Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued)

Revision on Renal Sympathetic Ablation in the Treatment of Resistant Hypertension
Current Hypertension Reviews

Endocannabinoids and their Involvement in the Neurovascular System
Current Neurovascular Research

Potential of Combination of Bone Marrow Nucleated and Mesenchymal Stem Cells in Complete Spinal Cord Injury
Current Stem Cell Research & Therapy

Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report
CNS & Neurological Disorders - Drug Targets

Adenosine and Related Drugs in Brain Diseases: Present and Future in Clinical Trials
Current Topics in Medicinal Chemistry

Translational Methods for Non-Invasive Electrical Stimulation to Facilitate Gait Rehabilitation Following Stroke - The Future Directions
Neuroscience and Biomedical Engineering (Discontinued)

Phosphodiesterase Type 5 Inhibitors: Unmet Needs
Current Pharmaceutical Design

Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca<sup>2+</sup> Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
CNS & Neurological Disorders - Drug Targets

Non-Selective Cation Channel Blockers: Potential Use in Nervous System Basic Research and Therapeutics
Mini-Reviews in Medicinal Chemistry

Multifunctional Therapeutic Delivery Strategies for Effective Neuro-Regeneration Following Traumatic Spinal Cord Injury
Current Pharmaceutical Design

The Therapeutic Potential of Neuro-EPO Administered Nasally on Acute Cerebrovascular Disease
Current Psychopharmacology

Purinergic Signalling and Endothelium
Current Vascular Pharmacology

Gabapentin and Pregabalin for the Acute Post-operative Pain Management. A Systematic-narrative Review of the Recent Clinical Evidences
Current Drug Targets

Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design

© 2025 Bentham Science Publishers | Privacy Policy